Profusa Announces Initial $1 Million Bitcoin Investment to Initiate Its Digital Asset Treasury Strategy
Profusa (NASDAQ: PFSA), a commercial stage digital health company, has announced its initial $1 million investment in Bitcoin (BTC) as part of its digital asset treasury strategy. The company has partnered with BlockFills, a global crypto trading solutions provider, to execute its BTC treasury management strategy.
The investment represents Profusa's strategic move to hedge against macroeconomic uncertainties, reflecting its conviction in Bitcoin as a digital store of value. The company is collaborating with Ascent Partners Fund to establish a cost-efficient Bitcoin treasury strategy while maintaining sufficient capital for its AI-driven digital health platform development.
Profusa (NASDAQ: PFSA), una società di digital health in fase commerciale, ha annunciato il suo investimento iniziale di 1 milione di dollari in Bitcoin (BTC) come parte della sua strategia di tesoreria in asset digitali. L'azienda ha stretto una collaborazione con BlockFills, un fornitore globale di soluzioni per il trading di criptovalute, per implementare la sua strategia di gestione della tesoreria in BTC.
Questo investimento rappresenta una mossa strategica di Profusa per proteggersi dalle incertezze macroeconomiche, confermando la sua fiducia in Bitcoin come riserva digitale di valore. La società sta lavorando con Ascent Partners Fund per sviluppare una strategia di tesoreria in Bitcoin efficiente in termini di costi, mantenendo al contempo un capitale sufficiente per lo sviluppo della sua piattaforma di digital health basata su intelligenza artificiale.
Profusa (NASDAQ: PFSA), una empresa de salud digital en etapa comercial, ha anunciado su inversión inicial de 1 millón de dólares en Bitcoin (BTC) como parte de su estrategia de tesorería en activos digitales. La compañía se ha asociado con BlockFills, un proveedor global de soluciones de comercio de criptomonedas, para ejecutar su estrategia de gestión de tesorería en BTC.
La inversión representa un movimiento estratégico de Profusa para cubrirse contra incertidumbres macroeconómicas, reflejando su convicción en Bitcoin como reserva digital de valor. La empresa colabora con Ascent Partners Fund para establecer una estrategia de tesorería en Bitcoin rentable, manteniendo suficiente capital para el desarrollo de su plataforma de salud digital impulsada por IA.
Profusa (NASDAQ: PFSA)는 상업 단계의 디지털 헬스 회사로서, 디지털 자산 재무 전략의 일환으로 비트코인(BTC)에 100만 달러 초기 투자를 발표했습니다. 회사는 글로벌 암호화폐 거래 솔루션 제공업체인 BlockFills와 협력하여 BTC 재무 관리 전략을 실행하고 있습니다.
이번 투자는 거시경제 불확실성에 대비한 Profusa의 전략적 조치로, 비트코인을 디지털 가치 저장 수단으로서 신뢰하고 있음을 반영합니다. 회사는 Ascent Partners Fund와 협력하여 비용 효율적인 비트코인 재무 전략을 수립하는 동시에 AI 기반 디지털 헬스 플랫폼 개발을 위한 충분한 자본을 유지하고 있습니다.
Profusa (NASDAQ : PFSA), une entreprise de santé numérique en phase commerciale, a annoncé son premier investissement d’un million de dollars en Bitcoin (BTC) dans le cadre de sa stratégie de trésorerie en actifs numériques. La société s’est associée à BlockFills, un fournisseur mondial de solutions de trading de cryptomonnaies, pour exécuter sa stratégie de gestion de trésorerie en BTC.
Cet investissement représente une démarche stratégique de Profusa pour se prémunir contre les incertitudes macroéconomiques, reflétant sa confiance en Bitcoin comme réserve de valeur numérique. L’entreprise collabore avec Ascent Partners Fund afin d’établir une stratégie de trésorerie en Bitcoin rentable tout en conservant un capital suffisant pour le développement de sa plateforme de santé numérique pilotée par l’IA.
Profusa (NASDAQ: PFSA), ein Unternehmen im Bereich digitale Gesundheit in der kommerziellen Phase, hat seine erste Investition von 1 Million US-Dollar in Bitcoin (BTC) im Rahmen seiner Digital-Asset-Treasury-Strategie bekannt gegeben. Das Unternehmen hat eine Partnerschaft mit BlockFills, einem globalen Anbieter von Krypto-Handelslösungen, geschlossen, um seine BTC-Treasury-Management-Strategie umzusetzen.
Die Investition stellt einen strategischen Schritt von Profusa dar, um sich gegen makroökonomische Unsicherheiten abzusichern und spiegelt das Vertrauen in Bitcoin als digitalen Wertspeicher wider. Das Unternehmen arbeitet mit Ascent Partners Fund zusammen, um eine kosteneffiziente Bitcoin-Treasury-Strategie zu entwickeln und gleichzeitig ausreichendes Kapital für die Entwicklung seiner KI-gesteuerten digitalen Gesundheitsplattform zu erhalten.
- Strategic $1 million Bitcoin investment to hedge against macroeconomic uncertainties
- Partnership with established crypto trading solutions provider BlockFills
- Capital-efficient approach to digital asset treasury management
- Exposure to volatile cryptocurrency market risks
- Allocation of capital away from core digital health business
BERKELEY, Calif, July 30, 2025 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”) (NASDAQ: PFSA), a commercial stage digital health company pioneering the next generation of technology platform enabling the continuous monitoring of an individual’s biochemistry, announces its initial
"It is important that we diligently execute on our digital treasury strategy designed to maximize our Bitcoin investment and maintain sufficient capital to provide the best-in-class, AI-driven digital health platform for the benefit of chronic disease and health and wellness management. These activities will help ensure that we are appropriately managing our resources and facilitating shareholder value. This initial investment is an important first step in our collaboration with Ascent Partners Fund to establish a low cost, capital efficient, best of breed, Bitcoin treasury strategy reflecting our strong conviction in Bitcoin as the digital store of value for the future and our dedication to driving our healthcare programs forward,” said Ben Hwang, Ph.D., Profusa’s Chairman and CEO.
About Profusa
Based in Berkeley, Calif., Profusa is a commercial stage digital health company led by visionary scientific founders, an experienced management team and a world-class board of directors in the development of a new generation of tissue-integrated sensors to detect and continuously transmit actionable, medical-grade data for personal and medical use. With its long-lasting, injectable and affordable biosensors and its intelligent data platform, Profusa aims to provide people with a personalized biochemical signature rooted in data that clinicians can trust and rely on.
“LUMEE”, “PROFUSA” and the PROFUSA logo are registered trademarks of Profusa Inc. in the United States, Canada, European Union, China, Japan, South Korea and Australia.
For more information, visit https://profusa.com.
Special Note Regarding Forward-Looking Statements
Certain statements in this press release (this “Press Release”) may be considered “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements generally relate to future events or future financial or operating performance of Profusa or the combined company. In some cases, you can identify forward-looking statements by terminology such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “forecast,” “future,” “intend,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “propose,” “seek,” “should,” “strive,” “will,” or “would” or the negatives of these terms or variations of them or similar terminology. Such forward-looking statements are subject to risks, uncertainties, and other factors which may be beyond the control of Profusa and could cause actual results to differ materially from those expressed or implied by such forward-looking statements, including risks regarding the highly volatile nature of the price of Bitcoin and other cryptocurrencies, as well as the risk that the Company's stock price may be highly correlated to the price of the digital assets that it holds. These forward-looking statements are based upon estimates and assumptions that, while considered reasonable by Profusa and its management are inherently uncertain. Profusa cautions you that these statements are based on a combination of facts and factors currently known and projections of the future, which are inherently uncertain. There are risks and uncertainties described in the definitive proxy/final prospectus relating to the business combination, which has been filed with the SEC, and described in other documents filed by Profusa from time to time with the SEC. These filings may identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Profusa cannot assure you that the forward-looking statements in this communication will prove to be accurate.
Contacts
Investor and Media Contacts
email: info@coreir.com
phone: 1 (212) 655-0924
FAQ
How much did Profusa (PFSA) invest in Bitcoin in July 2025?
Who is Profusa partnering with for its Bitcoin treasury management?
Why is Profusa (PFSA) investing in Bitcoin?
What is Profusa's core business?
Will Profusa make additional Bitcoin investments?
